Presentation is loading. Please wait.

Presentation is loading. Please wait.

Subcategorization of Lung Cancer Based on Tumor Size and Degree of Visceral Pleural Invasion⁎  Noriaki Sakakura, MD, Shoichi Mori, MD, Katsuhiro Okuda,

Published byAlajos Pásztor Modified over 5 years ago

Similar presentations

Presentation on theme: "Subcategorization of Lung Cancer Based on Tumor Size and Degree of Visceral Pleural Invasion⁎  Noriaki Sakakura, MD, Shoichi Mori, MD, Katsuhiro Okuda,"— Presentation transcript:

1 Subcategorization of Lung Cancer Based on Tumor Size and Degree of Visceral Pleural Invasion⁎ 
Noriaki Sakakura, MD, Shoichi Mori, MD, Katsuhiro Okuda, MD, Takayuki Fukui, MD, Shunzo Hatooka, MD, Masayuki Shinoda, MD, Keitaro Matsuo, MD, MS, Yasushi Yatabe, MD, Kohei Yokoi, MD, Tetsuya Mitsudomi, MD  The Annals of Thoracic Surgery  Volume 86, Issue 4, Pages (October 2008) DOI: /j.athoracsur Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Survival curves for the pathologic stages defined using the current TNM classification system. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Survival curves based on tumor size. (A) The cases were divided into six groups. (B) The cases were divided into three groups. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 (A) Survival curves based on the degree of pleural invasion. (B) Survival curves based on the nodal status. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Analysis to stratify the pathologic T2 category into subcategories based on tumor size and the degree of visceral pleural invasion classified according to the criteria from the Japan Lung Cancer Society (P factor). The 5-year survival rates of each group are shown in the upper section of each cell. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

6 Fig 5 (A) Survival curves based on our proposed pathologic T definition. (B) Survival curves based on the modified pathologic TNM staging system. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Subcategorization of Lung Cancer Based on Tumor Size and Degree of Visceral Pleural Invasion⁎  Noriaki Sakakura, MD, Shoichi Mori, MD, Katsuhiro Okuda,"

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer  Takayuki Fukui, MD, Shoichi Mori, MD, Kohei Yokoi, MD, Tetsuya.

Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer  Takayuki Fukui, MD, Shoichi Mori, MD, Kohei Yokoi, MD, Tetsuya.
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer  Jeffrey L. Port, MD, Bhupesh Parashar,

A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer  Jeffrey L. Port, MD, Bhupesh Parashar,
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 
Benny Weksler, MD, Jennifer L. Sullivan, MD 

Benny Weksler, MD, Jennifer L. Sullivan, MD 
Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Matthew D. Taylor, MD, Alykhan S. Nagji, MD, Castigliano M

Matthew D. Taylor, MD, Alykhan S. Nagji, MD, Castigliano M
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Lung Cancer Staging: A Case for a New T Definition

Lung Cancer Staging: A Case for a New T Definition
Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.

Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery 

Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery 
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,
Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy  Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy  Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Similar presentations

Ads by Google